阿托伐他汀与瑞舒伐他汀应该选哪一种呢？

The therapeutic effect of statins due to their cholesterol-lowering properties has been widely used in the primary and secondary prevention of cerebral infarction. Current studies have proven that both rosuvastatin and Atorvastatin can improve the depression scores of patients with cerebral infarction, relieve patients' pain, and improve patients' quality of life. So, which one should I choose, atorvastatin or rosuvastatin?

Atorvastatin and rosuvastatin both belong to the statin class and are commonly used drugs in the treatment of coronary heart disease. The pharmacological effect of atorvastatin is to selectively and competitively inhibit the production of reductase and reduce the conversion of mevalonate. After use, it can reduce the production of high-density lipoprotein cholesterol in the patient's body, thereby calming the blood lipid index and keeping it stable, thus controlling the progression of the patient's disease and prolonging the patient's survival.

Although rosuvastatin and atorvastatin belong to the same class of statins, after entering the human body, rosuvastatin can control the cholesterol precursor mevalonate, and the drug effect acts on the liver. After the drug takes effect, it increases the number of cells on the surface of the liver's high-density lipoprotein cholesterol receptors, thereby improving the liver's metabolism and decomposition of high-density lipoprotein cholesterol, thereby keeping the patient's blood lipid indicators stable and having a high clinical therapeutic value.

Both drugs have their own merits, and the specific choice of rosuvastatin or atorvastatin for clinical treatment actually depends on the patient's condition and physical condition. This decision must be made by a professional doctor after a comprehensive evaluation of you. Do not make it on your own.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.